Korean Tickers
KRX in English

Home Markets Stocks Financials Guide

Newsfeed Insights Earnings Broker research

Korean Tickers
KRX in English

Home Markets Stocks Financials Guide

Newsfeed Insights Earnings Broker research

Market Pulse

Daily · Nov 6, 2026 · data.go.kr + ECOS

KOSPI

5,059.69

-324.11 (-6.02%)

KOSDAQ

644.27

-34.14 (-5.03%)

KOSPI 200

783.23

-54.55 (-6.51%)

USD/KRW

1,356.60

Home›Reports›006280

006280KOSPI·May 11, 2026

Alyglo performance beats expectations

GC Biopharma Corp.Mirae Asset SecuritiesMihwa Seo

Read original PDF ↗

Source: Mirae Asset Securities
Type: Company Analysis
Language: English
Rating: Buy
Target price: -
Collected: Jun 03, 2026

The full report is published by Mirae Asset Securities. Korean Tickers provides its source link and metadata.

More research on 006280

3Q26 preview: Operating profit likely improvedMirae Asset Securities · Oct 22, 2026 2Q26 preview: Earnings set to improve in 2HMirae Asset Securities · Jul 23, 2026 4Q25 preview: Alyglo growth to ease concernsMirae Asset Securities · Jan 16, 2026 3Q25 review: In-line resultsMirae Asset Securities · Nov 04, 2025 2Q25 results likely to ease concernsMirae Asset Securities · Jul 23, 2025 Earnings improve on increased sales of high-margin productsMirae Asset Securities · May 07, 2025

All reports for 006280 →

Advertisement

Korean Tickers·Research reference for Korean listed companies.

Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.

KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources

Terms Refunds Disclaimer Privacy